Health & Safety Industry Today

Endometrial Cancer Therapeutics Industry – Treatment Analysis,Research,Review to 2023

WiseGuyReports.Com Publish a New Market Research Report On –“ Endometrial Cancer Therapeutics Industry – Treatment Analysis,Research,Review to 2023”.
Published 06 March 2019
Endometrial Cancer Therapeutics Industry 2019


Endometrial Carcinoma is a common form of cancer of the female reproductive system that initiates in the lining of the uterus. According to the American Cancer Society, endometrial cancer is also the most common cancer of the female reproductive organs in the US. About 60,050 new cases of cancer of uterus were estimated to be diagnosed during 2016, and about 10,470 women died from cancers of the uterine body during the same year.Early detection of endometrial cancer helps in the selection of proper treatment options. Endometrial Cancer can be treated by one or combination of therapies, such as chemotherapy, radiation therapy, hormone therapy, and surgery. Most of the physicians generally recommend combination treatments because chemotherapy alone has conventionally been deemed ineffective. Furthermore, adjuvant radiation therapy is ideal in patients who have diagnosed with Stage I or II endometrial cancer. Radiation Therapy is also recommended in patients who have undergone the surgery to avoid the relapse of endometrial cancer.
Get a Sample Report @

For more information or any query mail at
The “Global Endometrial Cancer Therapeutics Market By Therapy (Chemotherapy, Hormone Therapy, Radiation Therapy, Surgery), By Enduser (Research Institutes, Hospitals & Clinics), & Pipeline Analysis, Outlook to 2023”, the Endometrial Cancer therapeutics market is poised to reach approximately US$ 27 Billion by 2023. In this report, there is in-depthmarket analysis as well as market segmentation of global endometrial cancer therapeutics. The market potential of endometrial cancer therapeutic drugsisestimated considering that these are being tested in clinical trials for endometrial cancer, besides the ones which have already been approved. The depictedendometrial cancer therapeutic drugsare expected to show their complete market potential soon in the coming years.

Furthermore, in this report we have structured the information on epidemiology of endometrial cancer in the world. The report also covers pipeline analysis of endometrial cancer therapeutic drugs at various stages of clinical development that are under research or in collaboration, and those individually being developed by companies. Moreover, our report places an emphasis on the major drivers and challenges, latest trends and developments,as well as strategic collaborations that can impact industry’s growth.

In the end, the report enlists some of the key players in the Endometrial Cancer Therapeutics market including business overview of each player along with their product and pipeline portfolios, recent developments, and comparative analysis of their strengths and weaknesses.Conclusively, the report will prove to be a complete and comprehensive source of knowledge and analysis for clients and potential investors or debut makers in this industry.
Enquiry About Report @
Table Of Contents – Major Key Points

1. Analyst View 

2. Research Methodology 

3. Endometrial Cancer - Epidemiology & Risk Factors 

4. Endometrial Cancer Therapeutics - An Introduction 

5. Market Dynamics 
5.1 Drivers 
5.1.1 Rising Global Endometrial Cancer Epidemics 
5.1.2 Obesity Fuelling Endometrial Cancer Incidences 
5.1.3 Increasing Healthcare Expenditure 
5.2 Challenges 
5.2.1 High Cost Associated with the Treatment 
5.2.2 Increasing Stringency in Regulatory Requirements 

6. Endometrial Cancer Therapeutics Market Outlook to 2023 
6.1 Market Potential 

7. Market Segmentation 
7.1 By Therapy 
7.1.1 Chemotherapy 
7.1.2 Hormonal Therapy 
7.1.3 Radiation Therapy 
7.1.4 Surgery 
7.2 By End Users 
7.2.1 Research Institutes & CROs 
7.2.2 Hospitals & Clinics 
7.3 By Geography 
7.3.1 North America 
7.3.2 Europe 
7.3.3 Asia Pacific 
7.3.4 Rest of the World 

8. Endometrial Cancer Therapeutic Drugs Pipeline Analysis 
8.1 By Industry 
8.1.1 By Clinical Phase 
8.2 By Research Collaborations 
8.2.1 By Clinical Phase 

9. Trends and Developments 
9.1 Womb Lining Models for further Endometriosis Investigation 
9.2 Whole Exome Sequencing Aiding Identification of Targeted Therapies 
9.3 Sentinel Lymph-node Mapping: Less Invasive Method for Staging 
9.4 Metformin Holds Promise for Treating Endometrial Cancer 
9.5 Adjuvant Chemotherapy Feasible for High Risk Endometrial Cancer 


Buy 1-user PDF @

Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Other Industry News

Ready to start publishing

Sign Up today!